Pediatric Medication Studies: A New Challenge for Institutional Review Boards, Ethics Committees

Institutional review boards and ethics committees have seen it as their main task in the past few decades to protect children from questionable studies; however, they are faced with a new challenge with pediatric drug development.

Related Keywords

New York ,United States ,Riehen ,Basel Stadt ,Switzerland ,Hastings Center ,London ,City Of ,United Kingdom ,Washington ,Helsinki ,Eteläuomen Läi ,Finland ,American ,J Clin Pharmacol ,J Womens Dermatol ,Chemother Pharmacol ,Klaus Rose ,Josef Mengele ,Earlb Ettienne ,College Of Pharmacy ,World Medical Association ,European Medicines Agency ,European Society For Developmental ,Development Of Paediatric Medicines In Europe ,Oxford University ,Us Public Health Service ,Behavioral Research ,Elsevier ,Ethics International ,National Research ,Oxford University Press ,American Academy Of Pediatrics ,Ethical Principles For Medical Research Involving Human ,Expert Group ,Pediatric Drug Development ,Office For Human Research Protection ,European Union ,Howard University ,World War ,Tuskegee Study ,Health Service ,National Research Act ,Belmont Report ,Human Research Protection ,American Academy ,Assistant Dean ,Graduate Programs ,Industrial Partnerships ,Tuskegee Syphilis ,Hastings Center Report ,Disease Control ,Health Service Syphilis Study ,Human Subjects ,National Commission ,Medical Association ,Ethical Principles ,Medical Research Involving Human ,Nazi Doctors ,Pediatric Drug ,Clinical Studies ,Worldwide Ethical Challenge ,Ethics International Press ,Rambam Maimonides Med ,Medicines Agency ,Paediatric Medicines ,Pediatr Drugs ,Conflicts Of Interest ,Intj Womens Dermatol ,Largest Abuse ,Medical Research ,Dev Disabil Res ,European Society ,Paediatric Pharmacology White ,Better Medicines ,